IP Library Granted Patent US 12,228,555
Granted Patent B2
US 12,228,555 · App. 17/261,084 · Granted Feb 18, 2025

Self-contained biological indicator

Inventors: Francois Ahimou (Woodbury, MN); Kelvin J. Witcher (Hudson, WI); Naiyong Jing (Saint Paul, MN); Tonya D. Bonilla (Woodbury, MN); G. Marco Bommarito (Stillwater, MN)
Assignee: Solventum Intellectual Properties Company
G01N31/226A61L2/28C12Q1/22G01N21/6428G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,228,555
App. No.
17/261,084
Granted
Feb 18, 2025
Kind
B2
Abstract

The present disclosure is directed to self-contained biological indicators wherein a single type of indicator is capable of being used for various sterilization conditions, including sterilization with steam and/or ethylene oxide. In some embodiments, a single type of biological indicator is capable of being used for different steam sterilization conditions having varied temperatures and sterilization cycles.

Claims (17)

1. A self-contained biological indicator comprising:

a housing;

a source of biological activity, the source comprising and/or capable of producing an enzyme capable of catalyzing a cleavage of an enzyme substrate; and

an actuatable container comprising a liquid composition, comprising the enzyme substrate, wherein the enzyme substrate comprises a fluorophore component that, when separated from the enzyme substrate by the enzyme, comprises 7-hydroxy-2H-chromen-2-one or a derivative thereof;

wherein the actuatable container can be actuated to allow the liquid composition to contact a bacterial spore; and

wherein the source of biological activity and/or the liquid composition comprises an effective amount of an acidic component and/or a basic component such that, when the source of biological activity and the liquid composition are combined, a resulting mixture of the source of biological activity and the liquid composition has an initial pH greater than or equal to a pKa of a hydroxyl group of the fluorophore component.

2. The self-contained biological indicator of claim 1 , wherein the fluorophore component is selected from the group consisting of 4-methyl-5-fluoro-2H-chromen-2-one, 4-methyl-6-fluoro-2H-chromen-2-one, 4-methyl-8-fluoro-2H-chromen-2-one, 4-methyl-6,8-difluoro-2H-chromen-2-one, 4-methyl-6-chloro-2H-chromen-2-one, and 4-methylethanoate-6-fluoro-2H-chromen-2-one.

3. The self-contained biological indicator of claim 1 , wherein the enzyme is selected from the group consisting of α-glucosidase, α-galactosidase, lipase, esterase, acid phosphatase, alkaline phosphatase, proteases, aminopeptidase, chymotrypsin, β-glucosidase, β-galactosidase, α-glucoronidase, β-glucoronidase, phosphohydrolase, plasmin, thrombin, trypsin, calpain, α-mannosidase, β-mannosidase, a-L-fucosidase, leucine aminopeptidase, a-L-arabinofuranosidase, cysteine aminopeptidase, valine aminopeptidase, β-xylosidase, α-L-iduronidase, glucanase, cellobiosidase, cellulase, α-arabinosidase, glycanase, sulfatase, butyrate, glycosidase, arabinosidase, and a combination thereof.

4. The self-contained biological indicator of claim 1 , wherein the enzyme substrate comprises a derivative of 4-methylumbelliferone or a derivative of 7-amino-4-methylcoumarin.

5. The self-contained biological indicator of claim 1 , wherein the enzyme comprises α-D-glucosidase, wherein the enzyme substrate comprises 4-methylumbelliferyl-α-D-glucopyranoside.

6. A system, comprising

the self-contained biological indicator of claim 1 ; and

an automated reader configured to:

receive at least a portion of the self-contained biological indicator;

direct a first wavelength of electromagnetic radiation into the liquid composition in the housing; and

detect or measure a quantity of a second wavelength of electromagnetic radiation emitted by a fluorescent product.

7. The system of claim 6 , wherein the self-contained biological indicator is adapted to be used to determine efficacy of any steam sterilization process selected from the group consisting of 121° C. gravity process, 121° C. pre-vac process, 121° C. SFPP process, 132° C. gravity process, 132° C. pre-vac process, 132° C. SFPP process, 134° C. pre-vac process, 134° C. SFPP process, 135° C. gravity process, 135° C. pre-vac process, and 135° C. SFPP process.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066431/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2021
From: AHIMOU, FRANCOIS; WITCHER, KELVIN J.; JING, NAIYONG; BONILLA, TONYA D.; BOMMARITO, G. MARCO
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 054944/0641 →